Atlas Trials

Pilot Study to Evaluate the Safety and Efficacy of 5-ALA-SFC in Type II Diabetes

Clinical trial NCT02481141 · COMPLETED

Trial details

NCT number
NCT02481141
Sponsor
SBI Pharmaceuticals Co, Ltd.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2014-07-01
Primary completion
2015-07-01
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.